Amy Kelbick
Subscribe to Amy Kelbick's PostsAmy is a highly experienced health policy and advocacy professional who brings the benefit of nearly fifteen years of experience working on Capitol Hill in health-specific policy roles, and as a lobbyist and health policy specialist for a major national advocacy association. Read Amy Kelbick's full bio.
Medicare Coverage of Wegovy Raises Questions Regarding the Affordability and Accessibility of Novel Medications
By Jeffrey Davis, Paul Radensky, Parashar Patel and Amy Kelbick on May 15, 2024
Posted In Employee Benefits, Health and Welfare Plans
The Centers for Medicare & Medicaid Services (CMS) announced in March that it would allow health plans under Medicare Part D (the Medicare prescription drug benefit) to cover Wegovy and other weight-loss medications if they receive Food and Drug Administration (FDA) approval for an additional medically accepted indication. In Wegovy’s case, the FDA recently approved an additional...
Continue Reading
Pharmacy Benefit Manager Reform: What’s on the Horizon? (December 2023 Update)
By Leigh Feldman, Amy Kelbick, Rachel Stauffer, Erica Stocker and Katie Waldo on Dec 27, 2023
Posted In Employee Benefits, Health and Welfare Plans
The price of prescription drugs has brought scrutiny to the entire drug supply chain. Congress and other policymakers continue to seek opportunities to lower costs for patients and the federal government. Pharmacy benefit managers (PBMs) are a key stakeholder in the drug supply chain, functioning as intermediaries between insurance providers and pharmaceutical manufacturers. Congress and...
Continue Reading
Pharmacy Benefit Manager Reform: What’s on the Horizon?
By Rachel Stauffer, Katie Waldo, Amy Kelbick, Leigh Feldman and Erica Stocker on Oct 17, 2023
Posted In Employee Benefits, Health and Welfare Plans
The price of prescription drugs has brought scrutiny to the entire drug supply chain. Congress and other policymakers continue to seek opportunities to lower costs for patients and the federal government. Pharmacy benefit managers (PBMs) are a key stakeholder in the drug supply chain, functioning as intermediaries between insurance providers and pharmaceutical manufacturers. PBMs administer...
Continue Reading
Ending Free COVID Tests Risks Worsening the Pandemic
By Amy Kelbick and Eric Zimmerman on May 16, 2023
Posted In Employee Benefits, Health and Welfare Plans
The end of the COVID-19 public health emergency also means the end of coverage of self-administered, over-the-counter COVID tests. In this MedTech Dive opinion article, McDermott+Consulting’s Amy Kelbick and Eric Zimmerman argue that insurers, including Medicare, should continue to cover COVID tests at no cost and without requiring a prescription even after the public health...
Continue Reading
